StockData
OneMedNet Corp logo

OneMedNet Corp (ONMD) shareholders

ONMDNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as ONMDW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$4.95+0.09 (+1.85%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1M
Shares held, 13F filers
Institutional holders
22
6 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
14 buys · 6 sales
Net bought $4.01M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Off the Chain LP
Joint filing with Off the Chain Capital, LLC (9.50%)
3,215,6509.50%13G (passive)Sep 25, 2024
Td Securities (USA) LLC3,025,3386.20%13G (passive) amendmentSep 30, 2025
Cowen and Company, LLC2,970,8369.50%13G (passive)Sep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ONMDValueChange% of portfolio
Savant Capital, LLC721,924–$5.14MNew0.02%
Vanguard Capital Management LLC115,221–$819.22K+3,6640.00%
Geode Capital Management, LLC33,433–$237.71K−4200.00%
Vanguard Fiduciary Trust Co13,771–$97.91K+1100.00%
BlackRock, Inc.12,098–$86.02K+5,0880.00%
State Street Corp11,670–$82.97K–0.00%
Discovery Capital Management, LLC / Ct11,225–$79.81K–0.00%
PNC Financial Services Group, Inc.10,333–$73.47K+8,6070.00%
OpenArc Corporate Advisory, LLC9,741–$69.26K+8,6070.00%
Northern Trust Corp4,684–$33.30K−8100.00%
Captrust Financial Advisors3,260–$23.18KNew0.00%
Ashton Thomas Private Wealth, LLC2,660–$18.91K–0.00%
Toronto Dominion Bank2,360–$16.78KNew0.00%
Neuberger Berman Group LLC1,950–$13.87K–0.00%
UBS Group AG1,614–$11.47K−100.00%
Hrt Financial LP1,563–$11.00K−2,8450.00%
Procyon Advisors, LLC1,381–$9.82K–0.00%
Raymond James Financial Inc1,210–$8.60K–0.00%
Morgan Stanley1,182–$8.41KNew0.00%
Commonwealth Equity Services, LLC1,100–$7.82KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026221M6 / 54 / 41M0M
Q1 2026211M6 / 71 / 71M0M
Q4 2025231M10 / 73 / 40M1M
Q3 2025171M6 / 51 / 41M0M
Q2 2025151M3 / 23 / 50M0M
Q1 2025170M2 / 46 / 20M0M
Q4 2024170M2 / 37 / 50M0M
Q3 2024201M9 / 26 / 30M0M
Q2 2024140M11 / 30 / 40M0M
Q1 202470M4 / 21 / 30M0M
Q4 202360M6 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

10 funds held ONMD in Q2 2026, 82% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ONMDValue% of fundAs of
Vanguard Total Stock Market Index Fund845,040–$600.82K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund307,170–$218.40K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund158,498–$122.14K0.00%May 31, 2026
iShares Micro-Cap ETF47,503–$33.77K0.00%Jun 30, 2026
Fidelity Total Market Index Fund43,207–$33.30K0.00%May 31, 2026
Fidelity Series Total Market Index Fund41,177–$31.73K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund29,823–$22.98K0.00%May 31, 2026
1290 VT Micro Cap Portfolio3,381–$2.40K0.00%Jun 30, 2026
Avantis Total Equity Markets ETF909–$7000.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-6,069–-$4.32K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Jeffrey YuChief Medical Officer, Director, 10% owner1,028,037Oct 13, 2026
Aaron GreenChief Executive Officer, Director247,971Oct 9, 2026
Robert Lawrence GoldenChief Financial Officer, Director91,291Oct 9, 2026
Thomas KosasaDirector, 10% owner1,983,573Oct 13, 2026
Kenneth AlleyneDirector38,219Nov 26, 2025
Andrew B. ZeinfeldDirector381,525Nov 26, 2025
Sherry Coonse McCrawDirector56,342Nov 26, 2025
Eric CasaburiDirector110,475Nov 26, 2025
Jair ClarkeDirector138,485Nov 26, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Oct 9, 2026Buy+45,126$5.54$250.00K896,840
Thomas Kosasa
Director, 10% owner
Oct 7, 2026Buy+129,758$5.78$750.00K1,983,573
Aaron Green
Chief Executive Officer, Director
Sep 24, 2026Sale−1,667$6.48$10.80K247,971
Aaron Green
Chief Executive Officer, Director
Sep 22, 2026Sale−5,000$7.39$36.96K249,638
Robert Lawrence Golden
Chief Financial Officer, Director
Sep 21, 2026Sale−3,000$6.63$19.89K91,291
Robert Lawrence Golden
Chief Financial Officer, Director
Sep 15, 2026Sale−3,000$6.30$18.90K94,291
Robert Lawrence Golden
Chief Financial Officer, Director
Sep 14, 2026Sale−2,500$6.60$16.50K97,291
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Sep 10, 2026Buy+142,857$0.63$90.00K8,923,267
Thomas Kosasa
Director, 10% owner
Jul 30, 2026Buy+1,449,275$0.69$1,000.00K18,538,150
Robert Lawrence Golden
Chief Financial Officer, Director
Jul 6, 2026Award+35,000––99,791
Aaron Green
Chief Executive Officer, Director
Jul 6, 2026Award+65,000––254,638
Aaron Green
Chief Executive Officer, Director
Jun 23, 2026Buy+36,650$0.57$20.89K1,896,375
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Jun 23, 2026Buy+158,730$0.63$100.00K8,780,410
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Jun 16, 2026Buy+172,414$0.58$100.00K8,621,680
Aaron Green
Chief Executive Officer, Director
Jun 15, 2026Buy+18,702$0.54$10.10K1,859,725
Aaron Green
Chief Executive Officer, Director
Jun 12, 2026Buy+36,920$0.56$20.68K1,841,023
Thomas Kosasa
Director, 10% owner
Jun 12, 2026Buy+158,730$0.63$100.00K17,088,874
Thomas Kosasa
Director, 10% owner
May 18, 2026Buy+268,817$0.93$250.00K16,930,144
Thomas Kosasa
Director, 10% owner
Apr 23, 2026Buy+280,898$0.89$250.00K16,661,327
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Apr 1, 2026Award+219,429$0.83$182.13K8,449,266
Jeffrey Yu
Chief Medical Officer, Director, 10% owner
Apr 1, 2026Buy+903,614$0.83$750.00K8,229,837
Thomas Kosasa
Director, 10% owner
Feb 6, 2026Buy+595,238$0.84$500.00K16,380,429
Robert Lawrence Golden
Chief Financial Officer, Director
Jan 1, 2026Award+10,000––64,791
Eric Casaburi
Director
Nov 26, 2025Award+45,000––110,475
Kenneth Alleyne
Director
Nov 26, 2025Award+38,219––38,219
Jair Clarke
Director
Nov 26, 2025Award+45,000––138,485
Jeffrey Yu
Chief Medical Officer, Director
Nov 26, 2025Award+45,000––7,326,223
Sherry Coonse McCraw
Director
Nov 26, 2025Award+45,000––56,342
Thomas Kosasa
Director
Nov 26, 2025Award+45,000––15,785,191
Andrew B. Zeinfeld
Director
Nov 26, 2025Award+45,000––381,525
Aaron Green
Chief Executive Officer, Director
Nov 26, 2025Award+45,000––1,930,425
Robert Lawrence Golden
Chief Financial Officer, Director
Nov 26, 2025Award+45,000––547,905
Jeffrey Yu
Chief Medical Officer, Director
Nov 24, 2025Award+200,000––7,281,223
Aaron Green
Chief Executive Officer, Director
Nov 24, 2025Award+1,000,000––1,885,425
Robert Lawrence Golden
Chief Financial Officer, Director
Nov 24, 2025Award+33,333––502,905
Robert Lawrence Golden
Chief Financial Officer, Director
Nov 24, 2025Award+300,000––469,572
Aaron Green
Chief Executive Officer, Director
Nov 18, 2025Sale−61,555$1.20$73.87K1,804,103
Aaron Green
Chief Executive Officer, Director
Oct 22, 2025Sale−64,767$2.23$144.43K1,865,658
Eric Casaburi
Director
Oct 15, 2025Buy+10,000$3.05$30.50K65,475
Jeffrey Yu
Chief Medical Officer, Director
Sep 25, 2025Buy+1,250$1.03$1.29K7,081,223
Jeffrey Yu
Chief Medical Officer, Director
Sep 24, 2025Buy+17,200$1.02$17.54K7,079,973
Thomas Kosasa
Director
Sep 24, 2025Buy+6,000$0.93$5.58K15,740,191
Jeffrey Yu
Chief Medical Officer, Director
Sep 23, 2025Buy+5,700$0.93$5.30K7,062,773
Jeffrey Yu
Chief Medical Officer, Director
Sep 22, 2025Buy+400$0.95$3807,057,073
Jeffrey Yu
Chief Medical Officer, Director
Sep 19, 2025Buy+1,250$0.89$1.11K7,056,673
Jeffrey Yu
Chief Medical Officer, Director
Sep 18, 2025Buy+700$0.91$6377,055,423
Jeffrey Yu
Chief Medical Officer, Director
Sep 5, 2025Buy+2,100$0.86$1.81K7,054,723
Jeffrey Yu
Chief Medical Officer, Director
Sep 4, 2025Buy+11,810$0.87$10.27K7,052,623
Jeffrey Yu
Chief Medical Officer, Director
Sep 3, 2025Buy+11,670$0.81$9.45K7,040,813
Jeffrey Yu
Chief Medical Officer, Director
Sep 2, 2025Buy+24,319$0.85$20.67K7,029,143
Jeffrey Yu
Chief Medical Officer, Director
Aug 29, 2025Buy+10,890$0.82$8.93K7,004,824
Thomas Kosasa
Director
Aug 29, 2025Buy+581,395$0.86$500.00K15,734,191
Jeffrey Yu
Chief Medical Officer, Director
Aug 28, 2025Buy+17,000$0.80$13.60K6,993,934
Jeffrey Yu
Chief Medical Officer, Director
Aug 27, 2025Buy+21,374$0.69$14.75K6,976,934
Jeffrey Yu
Chief Medical Officer, Director
Aug 26, 2025Buy+173,350$0.69$119.61K6,955,560
Jeffrey Yu
Chief Medical Officer, Director
Aug 25, 2025Buy+13,300$0.75$9.98K6,782,210
Jeffrey Yu
Chief Medical Officer, Director
Aug 21, 2025Buy+15,000$0.77$11.55K6,768,910
Jeffrey Yu
Chief Medical Officer, Director
Aug 19, 2025Buy+16,500$0.77$12.71K6,753,910
Jeffrey Yu
Chief Medical Officer, Director
Jun 20, 2025Buy+1,666,666$0.42$700.00K6,737,410
Thomas Kosasa
Director
Jun 20, 2025Buy+1,190,476$0.42$500.00K15,152,796

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
5.8
At 0M shares a day
Change since last report
-11.9%
From 0M shares
Short volume, 20 days
52.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of OneMedNet's stock actually held short. Settlement fails (shares not delivered on time) peaked at 442,680 shares on Sep 24, 2026 over the last 90 days.

See a number that looks wrong?